Jiro Uemasu

405 total citations
26 papers, 314 citations indexed

About

Jiro Uemasu is a scholar working on Genetics, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Jiro Uemasu has authored 26 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Nephrology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Jiro Uemasu's work include Genetic and Kidney Cyst Diseases (7 papers), Biomedical Research and Pathophysiology (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Jiro Uemasu is often cited by papers focused on Genetic and Kidney Cyst Diseases (7 papers), Biomedical Research and Pathophysiology (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). Jiro Uemasu collaborates with scholars based in Japan and United States. Jiro Uemasu's co-authors include Hironaka Kawasaki, Masayuki Kitano, Hitoshi Kawasaki, H Kawasaki, Hirotaka Matsumoto, M. Fujiwara, Megumu Fujihara, Hideki Kawasaki, O. D. Jo and Chisato Hirayama and has published in prestigious journals such as Kidney International, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Jiro Uemasu

26 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiro Uemasu Japan 11 111 87 73 57 56 26 314
Eisaku Matsumoto Japan 10 60 0.5× 70 0.8× 52 0.7× 90 1.6× 49 0.9× 10 379
Laia Sans Spain 9 61 0.5× 95 1.1× 78 1.1× 27 0.5× 69 1.2× 32 275
JS Christiansen Denmark 13 74 0.7× 71 0.8× 84 1.2× 82 1.4× 79 1.4× 31 456
M Bescós Spain 8 68 0.6× 88 1.0× 49 0.7× 16 0.3× 31 0.6× 10 334
Øystein Aagenæs Norway 13 107 1.0× 74 0.9× 45 0.6× 65 1.1× 19 0.3× 23 417
Bashira A. Charles United States 7 78 0.7× 74 0.9× 60 0.8× 38 0.7× 31 0.6× 8 299
L W Elzinga United States 7 167 1.5× 123 1.4× 55 0.8× 21 0.4× 12 0.2× 11 340
Stella Feld United States 8 66 0.6× 167 1.9× 130 1.8× 30 0.5× 44 0.8× 9 416
Michael W. Steffes United States 9 42 0.4× 79 0.9× 246 3.4× 18 0.3× 51 0.9× 10 428
Bixia Zheng China 11 87 0.8× 158 1.8× 32 0.4× 40 0.7× 16 0.3× 66 401

Countries citing papers authored by Jiro Uemasu

Since Specialization
Citations

This map shows the geographic impact of Jiro Uemasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Uemasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Uemasu more than expected).

Fields of papers citing papers by Jiro Uemasu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Uemasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Uemasu. The network helps show where Jiro Uemasu may publish in the future.

Co-authorship network of co-authors of Jiro Uemasu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Uemasu. A scholar is included among the top collaborators of Jiro Uemasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Uemasu. Jiro Uemasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uemasu, Jiro, et al.. (2009). Effects of Chronic Administration of Somatostatin Analogue SMS 201–995 on the Progression of Chronic Renal Failure in Subtotal Nephrectomized Rats. Experimental and Clinical Endocrinology & Diabetes. 96(4). 97–104. 1 indexed citations
2.
Saito, Motoaki, Yukako Kinoshita, Itaru Satoh, et al.. (2006). N-hexacosanol ameliorates streptozotocin-induced diabetic rat nephropathy. European Journal of Pharmacology. 544(1-3). 132–137. 19 indexed citations
3.
Uemasu, Jiro, et al.. (2000). Association between Vitamin D Receptor Gene Polymorphisms and Renal Osteodystrophy in Patients on Maintenance Hemodialysis. Yonago acta medica. 43(1). 27–38. 3 indexed citations
4.
5.
Uemasu, Jiro, et al.. (1996). Cyst sclerotherapy with minocycline hydrochloride in patients with autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation. 11(5). 843–846. 18 indexed citations
6.
Kitano, Masayuki, Jiro Uemasu, & Hironaka Kawasaki. (1996). Increased urinary endothelin excretion in patients with liver cirrhosis. Journal of Gastroenterology and Hepatology. 11(4). 347–352. 6 indexed citations
7.
Uemasu, Jiro, et al.. (1996). Effects of low dose of recombinant human growth hormone on renal excretion of insulin-like growth factor-I (IGF-I) in humans: an inverse relation between serum and urinary IGF-I level.. PubMed. 46(1). 1–5. 6 indexed citations
8.
Uemasu, Jiro, et al.. (1994). Epidermal Growth Factor and Endothelin in Cyst Fluid From Autosomal Dominant Polycystic Kidney Disease Cases: Possible Evidence of Heterogeneity in Cystogenesis. American Journal of Kidney Diseases. 24(4). 561–568. 55 indexed citations
9.
Matsumoto, Hirotaka, Jiro Uemasu, Masayuki Kitano, & Hironaka Kawasaki. (1994). Clinical significance of plasma endothelin-1 in patients with chronic liver disease. Digestive Diseases and Sciences. 39(12). 2665–2670. 41 indexed citations
10.
Uemasu, Jiro, et al.. (1994). Inhibition of plasma endothelin-1 concentration by captopril in patients with essential hypertension.. PubMed. 41(3). 150–2. 14 indexed citations
11.
Uemasu, Jiro, et al.. (1993). Long-Term Effects of Enalapril in Rat with Experimental Chronic Tubulo-interstitial Nephropathy. American Journal of Nephrology. 13(1). 35–42. 5 indexed citations
12.
Uemasu, Jiro, Hirotaka Matsumoto, Masayuki Kitano, & Hironaka Kawasaki. (1993). Suppression of plasma endothelin-1 level by a α-human atrial natriuretic peptide and angiotensin converting enzyme inhibition in normal men. Life Sciences. 53(11). 969–974. 11 indexed citations
13.
Uemasu, Jiro, Megumu Fujihara, T Matsumoto, & Hiroaki Kawasaki. (1993). Acute Effects of Oral Glucose Loading on the Renin-Angiotensin-Aldosterone System in Patients with Chronic Renal Disease. Hormone and Metabolic Research. 25(2). 110–113. 1 indexed citations
14.
Uemasu, Jiro, et al.. (1993). Effects of topical instillation of minocycline hydrochloride on cyst size and renal function in polycystic kidney disease.. PubMed. 39(3). 140–4. 31 indexed citations
15.
Uemasu, Jiro, et al.. (1992). Increased Internal Calcium Mobilization in Platelets of Patients with Chronic Renal Failure. Hormone and Metabolic Research. 24(12). 588–592. 5 indexed citations
16.
Uemasu, Jiro, et al.. (1991). Effects of a Rice Meal on Renal Hemodynamics and Excretory Functions in Normal Subjects. ˜The œNephron journals/Nephron journals. 57(2). 187–191. 3 indexed citations
17.
Uemasu, Jiro, et al.. (1991). Effect of glucagon infusion on renal hemodynamics in normal subjects and patients with chronic glomerulonephritis.. Japanese Journal of Medicine. 30(1). 5–9. 1 indexed citations
18.
Kawasaki, H, et al.. (1989). Effect of renal prostaglandins on survival in patients with liver cirrhosis.. PubMed. 84(3). 285–9. 1 indexed citations
19.
Uemasu, Jiro, et al.. (1987). Prostaglandin E2 production by glomeruli and collecting tubules isolated from rat kidney.. The Japanese Journal of Physiology. 37(4). 631–641. 1 indexed citations
20.
Kawasaki, H, et al.. (1987). Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.. PubMed. 82(8). 727–31. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eisaku Matsumoto Breakdown of academic impact, for papers by Laia Sans Breakdown of academic impact, for papers by JS Christiansen Breakdown of academic impact, for papers by M Bescós Breakdown of academic impact, for papers by Øystein Aagenæs Breakdown of academic impact, for papers by Bashira A. Charles Breakdown of academic impact, for papers by L W Elzinga Breakdown of academic impact, for papers by Stella Feld Breakdown of academic impact, for papers by Michael W. Steffes Breakdown of academic impact, for papers by Bixia Zheng
Rankless by CCL
2026